First author Dr Alessandro Colasanti, from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, explained that PET imaging revealed immune activation in the hippocampus of patients with multiple sclerosis.
In fact, it is estimated that 10 to 20 percent of patients with multiple sclerosis, epilepsy chronic pain, and AIDS have admitted to smoking cannabis for therapeutic purposes.